These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38649690)

  • 1. Transcriptome and single-cell analysis reveal disulfidptosis-related modification patterns of tumor microenvironment and prognosis in osteosarcoma.
    Wang L; Liu Y; Tai J; Dou X; Yang H; Li Q; Liu J; Yan Z; Liu X
    Sci Rep; 2024 Apr; 14(1):9186. PubMed ID: 38649690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive investigation of tumor immune microenvironment and prognostic biomarkers in osteosarcoma through integrated bulk and single-cell transcriptomic analysis.
    Shi S; Zhang L; Guo X
    Front Immunol; 2024; 15():1424950. PubMed ID: 39108264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Risk Model and Genotyping Patterns Based on Disulfidptosis-Related lncRNAs to Predict Prognosis and Immune Landscape in Osteosarcoma.
    Zhang K; Lu S; Jiang M; Zou X; Chen C; Lan Y; Zhao H; Ma R; Yan H
    Front Biosci (Landmark Ed); 2024 May; 29(5):193. PubMed ID: 38812298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a pro-protein synthesis osteosarcoma subtype for predicting prognosis and treatment.
    Yi C; Liu J; Zhao S; Gong D; Xu B; Li A; Bian E; Tian D
    Sci Rep; 2024 Jul; 14(1):16475. PubMed ID: 39014082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
    Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
    BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
    Liu R; Hu Y; Liu T; Wang Y
    BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined analysis of DNA methylation and gene expression profiles of osteosarcoma identified several prognosis signatures.
    Tian W; Li Y; Zhang J; Li J; Gao J
    Gene; 2018 Apr; 650():7-14. PubMed ID: 29407229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcoma.
    Liu Y; Han X; Han Y; Bi J; Wu Y; Xiang D; Zhang Y; Bi W; Xu M; Li J
    Gene; 2024 May; 907():148286. PubMed ID: 38367852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Transcriptome Analysis Quantifies Immune Cell Transcript Levels, Metastatic Progression, and Survival in Osteosarcoma.
    Scott MC; Temiz NA; Sarver AE; LaRue RS; Rathe SK; Varshney J; Wolf NK; Moriarity BS; O'Brien TD; Spector LG; Largaespada DA; Modiano JF; Subramanian S; Sarver AL
    Cancer Res; 2018 Jan; 78(2):326-337. PubMed ID: 29066513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
    Yang H; Zhao L; Zhang Y; Li FF
    Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion.
    Liu YJ; Li W; Chang F; Liu JN; Lin JX; Chen DX
    Oncol Rep; 2018 Feb; 39(2):491-500. PubMed ID: 29251324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma.
    Meng Q; Zhao J; Liu H; Zhou G; Zhang W; Xu X; Zheng M
    Tumour Biol; 2014 Dec; 35(12):12265-74. PubMed ID: 25168370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of TNFRSF1A as a potential biomarker for osteosarcoma.
    Zhang Y; Liu K; Wang J
    Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell and spatial transcriptomics reveal metastasis mechanism and microenvironment remodeling of lymph node in osteosarcoma.
    Liu Y; He M; Tang H; Xie T; Lin Y; Liu S; Liang J; Li F; Luo K; Yang M; Teng H; Luo X; He J; Liao S; Huang Q; Feng W; Zhan X; Wei Q
    BMC Med; 2024 May; 22(1):200. PubMed ID: 38755647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfidptosis-related PABPC3 promotes tumor progression and inhibits immune activity in osteosarcoma.
    Cao Y; Wu S; Gu Y; Wong YH; Shi Y; Zhang L
    J Gene Med; 2024 Jan; 26(1):e3641. PubMed ID: 38058264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning survival prediction using tumor lipid metabolism genes for osteosarcoma.
    Li S; Zheng Z; Wang B
    Sci Rep; 2024 Jun; 14(1):12934. PubMed ID: 38839983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.
    Zhao S; Wang L; Ding W; Ye B; Cheng C; Shao J; Liu J; Zhou H
    Front Endocrinol (Lausanne); 2023; 14():1180404. PubMed ID: 37152941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.